Can Fibromyalgia Affect Your Heart Rate?

Fibromyalgia (FM) is a complex, chronic pain disorder characterized by widespread musculoskeletal pain, persistent fatigue, and significant cognitive difficulties often called “fibro fog.” Patients frequently report a host of other symptoms, including issues with heart function and rhythm. FM can affect your heart rate, and this connection stems from a physiological imbalance in the system that controls the body’s involuntary functions. Understanding this relationship can help validate patient experience and direct the path toward more targeted management strategies for these common cardiac-related symptoms.

The Role of the Autonomic Nervous System

The body’s heart rate regulation is managed by the Autonomic Nervous System (ANS), which operates automatically without conscious control to oversee functions like breathing, digestion, and blood pressure. The ANS is divided into two primary branches: the sympathetic nervous system (the “fight or flight” response) and the parasympathetic nervous system (the “rest and digest” counterpart). The sympathetic system accelerates heart rate during stress, while the parasympathetic system works to slow the heart rate and conserve energy.

In many individuals with fibromyalgia, this regulatory system becomes dysfunctional, a condition broadly described as dysautonomia. Studies utilizing Heart Rate Variability (HRV) analysis often reveal persistent sympathetic hyperactivity, meaning the “fight or flight” system is constantly overactive. This physiological state results in poor regulation of the heart’s rhythm and rate, leading to an elevated resting heart rate, a form of tachycardia. Low HRV indicates that the heart cannot adapt quickly to changing demands, signaling impaired autonomic modulation. This persistent imbalance helps explain heart rate irregularities and other common FM symptoms like postural intolerance, sleep disturbances, and chronic fatigue.

Associated Conditions Affecting Heart Rhythm

The dysfunction of the ANS frequently manifests as Postural Orthostatic Tachycardia Syndrome (POTS), a distinct form of dysautonomia commonly found in people with fibromyalgia. Research suggests a considerable overlap, with a notable percentage of individuals diagnosed with POTS also reporting symptoms consistent with FM.

For adults, POTS diagnostic criteria require a sustained increase in heart rate of 30 beats per minute or more within the first ten minutes of standing, without a significant drop in blood pressure. This rapid heart rate response upon changing posture is a direct consequence of the body’s failed attempt to compensate for decreased blood flow to the brain. Symptoms associated with this heart rate dysregulation can be intensely disruptive, often including palpitations, dizziness, and lightheadedness.

Patients may also experience presyncope, the sensation of nearly fainting, or a worsening of “fibro fog” when standing for extended periods. These orthostatic symptoms often intertwine with and exacerbate the general symptoms of fibromyalgia. Recognizing POTS helps distinguish the generalized fatigue of FM from fatigue triggered by gravitational stress and heart rate instability.

Identifying and Addressing Heart Rate Irregularities

Identifying heart rate irregularities linked to fibromyalgia and dysautonomia begins with a thorough evaluation by a medical professional, often a cardiologist or autonomic specialist. Initial diagnostic workup typically includes an electrocardiogram (ECG) and may utilize an echocardiogram to rule out any underlying structural heart disease. Continuous heart rate monitoring, such as a Holter monitor worn for 24 hours, can capture intermittent episodes of rapid or irregular heartbeats.

To confirm an ANS disorder like POTS, the Tilt Table Test is a specialized diagnostic procedure. During this test, the patient is strapped to a table that gradually tilts upright while heart rate and blood pressure are continuously monitored. This process observes the body’s response to standing and directly assesses its ability to maintain circulatory stability under gravitational stress, providing objective evidence of orthostatic intolerance.

Management strategies for these heart rate issues focus heavily on non-pharmacological interventions designed to improve blood volume and stabilize the circulatory system. Increasing the intake of fluids and sodium, often through high-salt foods or electrolyte supplements, is a first-line treatment to expand blood volume. Wearing compression garments, such as waist-high stockings, can also help by preventing blood from pooling in the lower extremities when upright.

Specific exercise protocols, such as beginning with reclined or recumbent exercises like rowing or cycling, are recommended to improve physical conditioning without overstraining the compromised ANS. Medications may also be considered, including beta-blockers, which can help lower an excessively high heart rate and alleviate palpitation symptoms. These pharmacological options require careful supervision by a specialist to tailor the treatment to the individual patient’s specific pattern of dysautonomia.